<DOC>
	<DOCNO>NCT01846351</DOCNO>
	<brief_summary>Study design evaluate effect significant ERM visual anatomic outcome intravitreal anti-VEGF therapy eAMD .</brief_summary>
	<brief_title>Intravitreal Anti-VEGF Exudative AMD With Epiretinal Membranes</brief_title>
	<detailed_description>Gass 1987 describe three case epiretinal membrane ( ERM ) associate wet macular degeneration . Since see rare find coexistence entity . An ERM may produce intrinsic disorganization outer retina lead persistent increase macular thickness and/or edema . This persistent edema may affect effectiveness treatment exudative age-related macular degeneration ( eAMD ) . Therefore , study design evaluate effect significant ERM visual anatomic outcome intravitreal anti-VEGF therapy eAMD .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Epiretinal Membrane</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Significant epiretinal membrane AntiVEGF treatment agerelated macular degeneration Uveitis Macular disorder Diabetic retinopathy Vascular occlusion</criteria>
	<gender>All</gender>
	<minimum_age>58 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>choroidal neovascularization</keyword>
	<keyword>epiretinal membrane</keyword>
	<keyword>anti-VEGF</keyword>
</DOC>